Detalhe da pesquisa
1.
Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
J Infect Dis
; 228(2): 143-148, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821777
2.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
MMWR Morb Mortal Wkly Rep
; 72(2): 39-43, 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634021
3.
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
Ann Intern Med
; 175(4): 513-522, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038274
4.
Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006-2020.
J Infect Dis
; 226(Suppl 4): S431-S440, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265846
5.
Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination.
Clin Infect Dis
; 75(1): e741-e748, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849680
6.
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.
MMWR Morb Mortal Wkly Rep
; 71(30): 971-976, 2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900925
7.
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(33): 1047-1051, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980875
8.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
MMWR Morb Mortal Wkly Rep
; 71(44): 1401-1406, 2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327162
9.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 249-254, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176008
10.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 347-351, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239637
11.
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
MMWR Morb Mortal Wkly Rep
; 71(28): 899-903, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834416
12.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
MMWR Morb Mortal Wkly Rep
; 71(3): 90-95, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051137
13.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298454
14.
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
JAMA
; 327(4): 331-340, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076665
15.
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
MMWR Morb Mortal Wkly Rep
; 70(5152): 1755-1760, 2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968370
16.
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 680-684, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956784
17.
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
MMWR Morb Mortal Wkly Rep
; 70(31): 1053-1058, 2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351881
18.
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MMWR Morb Mortal Wkly Rep
; 70(17): 651-656, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914723
19.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
MMWR Morb Mortal Wkly Rep
; 70(27): 977-982, 2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237049
20.
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
MMWR Morb Mortal Wkly Rep
; 70(32): 1094-1099, 2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383735